Home/Critical Appraisal
Critical Appraisal

Diagnostic Accuracy Biases

EM FINAL EXAMS Critical Appraisal · Diagnostics Diagnostic Accuracy Biases The study-design flaws that make a test look better than it really is. Definition Biases that distort a test’s apparent accuracy. Spectrum bias: the test looks better tested on the obviously-diseased versus the clearly-healthy than in the real diagnostic-dilemma population. Verification / work-up bias: only […]

EM FINAL EXAMS Critical Appraisal · Diagnostics

Diagnostic Accuracy Biases

The study-design flaws that make a test look better than it really is.

Definition

Biases that distort a test’s apparent accuracy. Spectrum bias: the test looks better tested on the obviously-diseased versus the clearly-healthy than in the real diagnostic-dilemma population. Verification / work-up bias: only index-test-positive patients go on to receive the reference standard. Incorporation bias: the index test is itself part of the reference standard. QUADAS-2 is the tool used to detect them.

The picture

Only the test-positive arm is verified → the missing 700 distort the accuracy

What it shows

A diagnostic study where the reference standard is applied selectively. Because the 700 test-negative patients never have their true disease status confirmed, the 2×2 table is built from a biased subset — the false-negatives that should sit in the bottom-left cell are simply never counted.

How to read it

Trace who actually reaches the reference standard. If verification depends on the index result (verification bias), if the cohort is florid cases versus healthy controls (spectrum bias), or if the index test helped decide the reference diagnosis (incorporation bias), the headline sensitivity and specificity are inflated and won’t hold in real practice.

Why it matters

These biases are the commonest reason a test dazzles in its first paper and disappoints in the ED. They inflate accuracy precisely in the direction that looks good for publication, so a critical reader must check how the study was built before trusting any quoted sensitivity or specificity.

Key
  • Spectrum = wrong population (obvious cases vs healthy)
  • Verification = reference standard applied selectively
  • Incorporation = index test is part of its own reference
Pitfall
Pitfall Trusting sensitivity and specificity from a case-control diagnostic study (florid disease versus healthy controls). Spectrum bias inflates both relative to real practice, where the hard work is the diagnostic grey zone, not the obvious cases.
emfinalexams.com · FRCEM / MRCEM revision
EM trial in the wild

QUADAS-2 (Whiting et al., Ann Intern Med 2011) is the standard tool for appraising diagnostic-accuracy studies, scoring four domains — patient selection, index test, reference standard, and flow & timing — for risk of bias and applicability. A worked example: a troponin assay evaluated only in patients who already proceeded to angiography (the reference standard) suffers verification bias, because angiography was offered selectively rather than to every patient tested. A glowing sensitivity / specificity from a case-control design or selective verification can collapse once the test meets the real, undifferentiated ED population.

Examiner traps
  • Spectrum bias — obvious cases vs healthy controls overstate accuracy.
  • Verification (work-up) bias — only test-positives get the reference standard.
  • Incorporation bias — the index test forms part of the reference standard.
Quick check

Why might a test’s published sensitivity overstate its real-world value?
Answer: Spectrum bias — it was evaluated on obvious cases versus healthy controls, not the diagnostic grey zone where the test is actually needed, so its accuracy is inflated relative to everyday practice.

Related cards

Ready to build your plan? EMF Premium gives you all 40,000+ questions, 20 mocks and 1,215 OSCE stations from £29/month — or a one-off 3- or 6-month pass.

Share
0
    0
    Your Cart
    Your cart is emptyReturn to Shop